Norma Frizzell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Norma Frizzell has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Alexander V. Alekseyenko
Medical University of South Carolina
10 shared publications - Alhaji H. Janneh
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina
10 shared publications - Besim Ogretmen
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, USA
10 shared publications - Chase Walton
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina
10 shared publications - Christina Voelkel-Johnson
Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, USA
10 shared publications - Elizabeth G. Hill
Department of Public Health Sciences Medical University of South Carolina Charleston South Carolina USA
10 shared publications
Latest Publications
- 16 October 2025
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 16 (21) , 4172-4179
Region-Specific Quantification of 2-Hydroxyglutarate Enantiomers in Murine Brain during Mitochondrial Complex I Deficiency
The Ndufs4-/- mouse is a model of mitochondrial Complex I deficiency that contributes to altered production of the tricarboxylic acid cycle metabolites. We hypothesized that l-2-hydroxyglutarate (l-2-HG) levels would be elevated in the pathologically affected regions of the Ndufs4-/- mouse brain in parallel with metabolic acidosis. We employed a stable isotope dilution method for the concurrent quantification of l-lactate and the distinct 2-HG enantiomers in isolated mouse brain regions. While lactate levels were elevated, as expected in the Ndufs4-/- brain, the levels of l-2-HG and the enantiomer d-2-HG were markedly reduced in a region-specific manner, and this decrease was also reproduced in the Ndufs4-/- serum. The specific and reproducible decreases in 2-HG quantified in Complex I deficiency may have utility as a unique disease biomarker. Quantitative analysis of the mitochondrial proteome of the Ndufs4-/- mouse brainstem indicated an increased abundance of l-2-HG dehydrogenase, suggesting that 2-HG enantiomers are metabolized in the Ndufs4-/- mouse yielding FADH2 to alleviate the bioenergetic deficit.
- 16 October 2025
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 16 (21) , 4172-4179
Region-Specific Quantification of 2-Hydroxyglutarate Enantiomers in Murine Brain during Mitochondrial Complex I Deficiency
The Ndufs4-/- mouse is a model of mitochondrial Complex I deficiency that contributes to altered production of the tricarboxylic acid cycle metabolites. We hypothesized that l-2-hydroxyglutarate (l-2-HG) levels would be elevated in the pathologically affected regions of the Ndufs4-/- mouse brain in parallel with metabolic acidosis. We employed a stable isotope dilution method for the concurrent quantification of l-lactate and the distinct 2-HG enantiomers in isolated mouse brain regions. While lactate levels were elevated, as expected in the Ndufs4-/- brain, the levels of l-2-HG and the enantiomer d-2-HG were markedly reduced in a region-specific manner, and this decrease was also reproduced in the Ndufs4-/- serum. The specific and reproducible decreases in 2-HG quantified in Complex I deficiency may have utility as a unique disease biomarker. Quantitative analysis of the mitochondrial proteome of the Ndufs4-/- mouse brainstem indicated an increased abundance of l-2-HG dehydrogenase, suggesting that 2-HG enantiomers are metabolized in the Ndufs4-/- mouse yielding FADH2 to alleviate the bioenergetic deficit.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
Effects of LCL768 on the growth of UM-SCC-1A-derived xenograft HNSCC tumors in vivo.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
Effects of LCL768 on the growth of UM-SCC-1A-derived xenograft HNSCC tumors in vivo.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Data from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
Bioactive ceramide induces cell death in part by promoting mitophagy. C18-ceramide levels are commonly reduced in head and neck squamous cell carcinoma, which correlates with poor prognosis, suggesting the potential of harnessing ceramide for cancer treatment. In this study, we evaluated the ability of the ceramide analog D-erythro-14-(1-pyridinium)-N-octadecanoyl-sphingosine selenite (LCL768) to induce mitophagy and metabolic stress in head and neck squamous cell carcinoma. Mechanistically, LCL768 induced ceramide synthase 1 (CerS1)–mediated endogenous C18-ceramide accumulation in mitochondria to mediate mitophagy, which did not require the CerS1 transporter p17/PERMIT but was dependent on DRP1 activation via nitrosylation at C644. DRP1 facilitated the anchoring of the endoplasmic reticulum (ER) and mitochondrial membranes by promoting the association between phosphatidylethanolamine in the ER and cardiolipin in mitochondrial membranes. Mutations of Drp1 that prevented its binding to ER and mitochondrial membranes blocked CerS1/C18-ceramide mitochondrial accumulation, inhibiting LCL768-mediated mitophagy. In addition, LCL768-driven mitophagy altered mitochondrial metabolism, resulting in fumarate depletion and leading to tumor suppression in vivo. Exogenous fumarate supplementation prevented LCL768-mediated mitophagy, mitochondrial trafficking of CerS1, ER–mitochondrial tethering, and tumor suppression in mice. Fumarate metabolism was associated with PARKIN succination at a catalytic cysteine (Cys431), inhibiting its association with PINK1 and ubiquitin, thereby preventing mitophagy. LCL768-induced fumarate depletion attenuated PARKIN succination to promote PARKIN activation and mitophagy, indicating a feedforward mechanism that regulates mitophagy and fumarate metabolism through PARKIN succination. These data provide a mechanism whereby LCL768/CerS1-C18-ceramide–mediated mitophagy and tumor suppression are regulated by Drp1 nitrosylation, fumarate depletion, and PARKIN succination, providing a metabolic stress signature for lethal mitophagy.Significance:The identification of a metabolic link between ceramide-induced mitophagy, fission, and fumarate depletion reveals an effective tumor suppressive strategy for head and neck squamous cell carcinoma.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
Bioactive ceramide induces cell death in part by promoting mitophagy. C18-ceramide levels are commonly reduced in head and neck squamous cell carcinoma, which correlates with poor prognosis, suggesting the potential of harnessing ceramide for cancer treatment. In this study, we evaluated the ability of the ceramide analog D-erythro-14-(1-pyridinium)-N-octadecanoyl-sphingosine selenite (LCL768) to induce mitophagy and metabolic stress in head and neck squamous cell carcinoma. Mechanistically, LCL768 induced ceramide synthase 1 (CerS1)–mediated endogenous C18-ceramide accumulation in mitochondria to mediate mitophagy, which did not require the CerS1 transporter p17/PERMIT but was dependent on DRP1 activation via nitrosylation at C644. DRP1 facilitated the anchoring of the endoplasmic reticulum (ER) and mitochondrial membranes by promoting the association between phosphatidylethanolamine in the ER and cardiolipin in mitochondrial membranes. Mutations of Drp1 that prevented its binding to ER and mitochondrial membranes blocked CerS1/C18-ceramide mitochondrial accumulation, inhibiting LCL768-mediated mitophagy. In addition, LCL768-driven mitophagy altered mitochondrial metabolism, resulting in fumarate depletion and leading to tumor suppression in vivo. Exogenous fumarate supplementation prevented LCL768-mediated mitophagy, mitochondrial trafficking of CerS1, ER–mitochondrial tethering, and tumor suppression in mice. Fumarate metabolism was associated with PARKIN succination at a catalytic cysteine (Cys431), inhibiting its association with PINK1 and ubiquitin, thereby preventing mitophagy. LCL768-induced fumarate depletion attenuated PARKIN succination to promote PARKIN activation and mitophagy, indicating a feedforward mechanism that regulates mitophagy and fumarate metabolism through PARKIN succination. These data provide a mechanism whereby LCL768/CerS1-C18-ceramide–mediated mitophagy and tumor suppression are regulated by Drp1 nitrosylation, fumarate depletion, and PARKIN succination, providing a metabolic stress signature for lethal mitophagy.Significance:The identification of a metabolic link between ceramide-induced mitophagy, fission, and fumarate depletion reveals an effective tumor suppressive strategy for head and neck squamous cell carcinoma.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
LCL768 reduces TCA cycle metabolism in HNSCC cells.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
LCL768 reduces TCA cycle metabolism in HNSCC cells.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
Effects of exogenous fumarate on HNSCC tumor metabolism in response to LCL768.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
Effects of exogenous fumarate on HNSCC tumor metabolism in response to LCL768.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
LCL768-mediated mitophagy is independent of p17, cell line, and induces Drp1’s nitrosylation.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
LCL768-mediated mitophagy is independent of p17, cell line, and induces Drp1’s nitrosylation.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
Drp1 mutations alter its ER or mitochondrial membrane interactions and change cancer metabolism by LCL768.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
Drp1 mutations alter its ER or mitochondrial membrane interactions and change cancer metabolism by LCL768.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
LCL768 inhibits mitochondrial bioenergetics via inducing mitophagy.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
LCL768 inhibits mitochondrial bioenergetics via inducing mitophagy.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression